Works matching AU Bepler, Gerold

Results: 65
    1
    2
    3

    A Randomized, Open-Label Phase II Study Evaluating Emibetuzumab Plus Erlotinib and Emibetuzumab Monotherapy in MET Immunohistochemistry Positive NSCLC Patients with Acquired Resistance to Erlotinib.

    Published in:
    Clinical Lung Cancer, 2022, v. 23, n. 4, p. 300, doi. 10.1016/j.cllc.2022.03.003
    By:
    • Camidge, D. Ross;
    • Moran, Teresa;
    • Demedts, Ingel;
    • Grosch, Heidrun;
    • Mileham, Kathryn;
    • Molina, Julian;
    • Juan-Vidal, Oscar;
    • Bepler, Gerold;
    • Goldman, Jonathan W.;
    • Keunchil Park;
    • Wallin, Johan;
    • Wijayawardana, Sameera R.;
    • Xuejing Aimee Wang;
    • Wacheck, Volker;
    • Smit, Egbert
    Publication type:
    Article
    4

    The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer.

    Published in:
    Clinical Lung Cancer, 2022, v. 23, n. 1, p. 52, doi. 10.1016/j.cllc.2021.08.012
    By:
    • Nagasaka, Misako;
    • Singh, Vijendra;
    • Baca, Yasmine;
    • Sukari, Ammar;
    • Kim, Chul;
    • Mamdani, Hirva;
    • Spira, Alexander I.;
    • Uprety, Dipesh;
    • Bepler, Gerold;
    • Kim, Edward S.;
    • Raez, Luis E.;
    • Pai, Sachin Gopalkrishna;
    • Ikpeazu, Chukwuemeka;
    • Oberley, Matthew;
    • Feldman, Rebecca;
    • Xiu, Joanne;
    • Korn, W. Michael;
    • Wozniak, Antoinette J.;
    • Borghaei, Hossein;
    • Liu, Stephen V.
    Publication type:
    Article
    5
    6
    7

    Chronic p27<sup>Kip1</sup> Induction by Dexamethasone Causes Senescence Phenotype and Permanent Cell Cycle Blockade in Lung Adenocarcinoma Cells Over-expressing Glucocorticoid Receptor.

    Published in:
    Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-34475-8
    By:
    • Patki, Mugdha;
    • McFall, Thomas;
    • Rosati, Rayna;
    • Huang, Yanfang;
    • Malysa, Agnes;
    • Polin, Lisa;
    • Fielder, Abigail;
    • Wilson, Mike R.;
    • Lonardo, Fulvio;
    • Back, Jessica;
    • Li, Jing;
    • Matherly, Larry H.;
    • Bepler, Gerold;
    • Ratnam, Manohar
    Publication type:
    Article
    8
    9

    Regular aspirin use and lung cancer risk.

    Published in:
    BMC Cancer, 2002, v. 2, p. 31, doi. 10.1186/1471-2407-2-31
    By:
    • Moysich, Kirsten B.;
    • Menezes, Ravi J.;
    • Ronsani, Adrienne;
    • Swede, Helen;
    • Reid, Mary E.;
    • Cummings, K. Michael;
    • Falkner, Karen L.;
    • Loewen, Gregory M.;
    • Bepler, Gerold
    Publication type:
    Article
    10
    11
    12
    13
    14

    Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 517, doi. 10.1007/s00262-018-2287-9
    By:
    • Chiappori, Alberto A.;
    • Williams, Charles C.;
    • Gray, Jhanelle E.;
    • Tanvetyanon, Tawee;
    • Haura, Eric B.;
    • Creelan, Ben C.;
    • Thapa, Ram;
    • Chen, Dung-Tsa;
    • Simon, George R.;
    • Bepler, Gerold;
    • Gabrilovich, Dmitry I.;
    • Antonia, Scott J.
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Molecular classification of nonsmall cell lung cancer using a 4-protein quantitative assay.

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 6, p. 1607, doi. 10.1002/cncr.26450
    By:
    • Anagnostou, Valsamo K.;
    • Dimou, Anastasios T.;
    • Botsis, Taxiarchis;
    • Killiam, Elizabeth J.;
    • Gustavson, Mark D.;
    • Homer, Robert J.;
    • Boffa, Daniel;
    • Zolota, Vassiliki;
    • Dougenis, Dimitrios;
    • Tanoue, Lynn;
    • Gettinger, Scott N.;
    • Detterbeck, Frank C.;
    • Syrigos, Konstantinos N.;
    • Bepler, Gerold;
    • Rimm, David L.
    Publication type:
    Article
    28
    29
    30
    31

    ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe.

    Published in:
    NAR Cancer, 2023, v. 5, n. 4, p. 1, doi. 10.1093/narcan/zcac045
    By:
    • Heyza, Joshua R;
    • Ekinci, Elmira;
    • Lindquist, Jacob;
    • Lei, Wen;
    • Yunker, Christopher;
    • Vinothkumar, Vilvanathan;
    • Rowbotham, Rachelle;
    • Polin, Lisa;
    • Snider, Natalie G;
    • Van Buren, Eric;
    • Watza, Donovan;
    • Back, Jessica B;
    • Chen, Wei;
    • Mamdani, Hirva;
    • Schwartz, Ann G;
    • Turchi, John J;
    • Bepler, Gerold;
    • Patrick, Steve M
    Publication type:
    Article
    32

    ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe.

    Published in:
    NAR Cancer, 2023, v. 5, n. 1, p. 1, doi. 10.1093/narcan/zcac045
    By:
    • Heyza, Joshua R.;
    • Ekinci, Elmira;
    • Lindquist, Jacob;
    • Wen Lei;
    • Yunker, Christopher;
    • Vinothkumar, Vilvanathan;
    • Rowbotham, Rachelle;
    • Polin, Lisa;
    • Snider, Natalie G.;
    • Van Buren, Eric;
    • Watza, Donovan;
    • Back, Jessica B.;
    • Wei Chen;
    • Mamdani, Hirva;
    • Schwartz, Ann G.;
    • Turchi, John J.;
    • Bepler, Gerold;
    • Patrick, Steve M.
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer.

    Published in:
    Oncogene, 2003, v. 22, n. 23, p. 3548, doi. 10.1038/sj.onc.1206419
    By:
    • Rosell, Rafael;
    • Scagliotti, Giorgio;
    • Danenberg, Kathleen D;
    • Lord, Reginald VN;
    • Bepler, Gerold;
    • Novello, Silvia;
    • Cooc, Janine;
    • Crino, Lucio;
    • Sanchez, Jose Javier;
    • Taron, Miquel;
    • Boni, Corrado;
    • Marinis, Filippo De;
    • Tonato, Maurizio;
    • Marangolo, Maurizio;
    • Gozzelino, Felice;
    • Costanzo, Franceso Di;
    • Rinaldi, Massimo;
    • Salonga, Dennis;
    • Stephens, Craig
    Publication type:
    Article
    48
    49
    50